Table 3 Relevant CT chest findings
Data | COPD (n = 50) | Non-COPD (n = 231) | OR (95% CI) | p value |
|---|---|---|---|---|
GGO distribution | ||||
Bilateral | 44 (88.0%) | 223 (96.5%) | 3.801 (1.257–11.497) | 0.023* |
Unilateral | 6 (12.0%) | 8 (3.5%) | 0.263 (0.087–0.796) | 0.023* |
Peripheral | 48 (96.0%) | 229 (99.1%) | 4.771 (0.656–34.710) | 0.147 |
Central | 36 (72.0%) | 194 (83.9%) | 2.039 (1.002–4.149) | 0.046* |
Right upper lobe | 43 (86.0%) | 216 (93.5%) | 2.344 (0.902–6.092) | 0.084 |
Right middle lobe | 40 (80.0%) | 205 (88.7%) | 1.971 (0.882–4.405) | 0.093 |
Right lower lobe | 43 (86.0%) | 223 (96.5%) | 4.538 (1.563–13.171) | 0.008* |
Left upper lobe | 46 (92.0%) | 219 (94.8%) | 1.587 (0.490–5.141) | 0.498 |
Left lower lobe | 42 (84.0%) | 220 (95.2%) | 3.810 (1.446–10.036) | 0.009* |
Other abnormalities | ||||
"Crazy-paving" pattern | 17 (34.0%) | 132 (57.1%) | 2.615 (1.378–4.963) | 0.003* |
Fibrous stripes | 11 (22.0%) | 82 (35.5%) | 1.951 (0.948–4.014) | 0.066 |
"Reversed halo" | 0 | 8 (3.5%) | 0.358 | |
Vascular enlargement | 42 (84.0%) | 204 (88.3%) | 1.439 (0.611–3.387) | 0.403 |
Pleural effusion | 5 (10.0%) | 7 (3.0%) | 0.281 (0.085–0.926) | 0.043* |
Mediastinal lymphadenopathy | 42 (84.0%) | 107 (46.3%) | 0.164 (0.074–0.365) | < 0.001* |
Diffuse alveolar damage | 1 (2.0%) | 6 (2.6%) | 1.307 (0.154–11.100) | 1.000 |
CT severity score | ||||
CT 1 | 19 (38.0%) | 52 (22.5%) | 0.474 (0.248–0.907) | 0.022* |
CT 2 | 17 (34.0%) | 83 (35.9%) | 1.089 (0.572–2.073) | 0.796 |
CT 3 | 10 (20.0%) | 65 (28.1%) | 1.566 (0.740–3.316) | 0.238 |
CT 4 | 4 (8.0%) | 30 (12.9%) | 1.716 (0.576–5.112) | 0.327 |